Producing a Vaccine Takes More Than a Patent

By Peter J. Hotez, Maria Elena Bottazzi and Prashant Yadav

Although President Joe Biden announced that the United States would support an international bid to waive intellectual property rights to vaccines for the duration of the coronavirus pandemic, the authors argue that producing vaccines requires not only patents but an entire infrastructure that cannot be transferred overnight. Foreign Affairs (subscription required):